IP Library Granted Patent US 7,011,850
Granted Patent B2
US 7,011,850 · App. 09/735,989 · Granted Mar 14, 2006

Dosage forms having a barrier layer to laser ablation

Assignee: Alza Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,011,850
App. No.
09/735,989
Granted
Mar 14, 2006
Kind
B2
Abstract

A dosage form for delivery of a therapeutic agent to a subject is described. The dosage form contains: (a) an outer wall defining an interior compartment; (b) within the interior compartment, a therapeutic agent; (c) at least one exit orifice formed by laser ablation of the outer wall for release of the agent therethrough, and (d) a barrier layer disposed between the outer wall and the interior compartment in at least a region corresponding to the exit orifice. The barrier layer comprises a material that allows the barrier layer to remain intact during laser-formation of the at least one exit orifice in the outer wall. Also disclosed is a method for controlling the depth of laser ablation of a dosage form during laser formation of an exit orifice in an outer wall of the dosage form.

Claims (25)

1. A dosage form comprising:

(a) an outer wall defining an interior compartment;

(b) a therapeutic agent within the interior compartment;

(c) at least one laser formed exit orifice in the outer wall; and

(d) a barrier layer disposed between the outer wall and the interior compartment in at least a region corresponding to the at least one exit orifice, wherein the barrier layer comprises a material that allows the barrier layer to remain intact during formation of the at least one laser formed exit orifice, wherein the material is present in the barrier layer in an amount sufficient to make the barrier layer substantially impervious to laser ablation under a selected laser type and selected laser operating conditions used to form the exit orifice.

2. The dosage form of claim 1 , wherein the outer wall comprises a semipermeable material.

3. The dosage form of claim 1 , wherein the barrier layer surrounds the interior compartment.

4. The dosage form of claim 1 , wherein the barrier layer is a contiguous film.

5. The dosage form of claim 1 , wherein the barrier layer is a non-contiguous porous film.

6. The dosage form of claim 1 , wherein the interior compartment contains a therapeutic agent in a solid state.

7. A dosage form comprising:

(a) an outer wall defining an interior compartment;

(b) a therapeutic agent within the interior compartment, wherein the interior compartment contains a therapeutic agent in a liquid state within a water-soluble capsule;

(c) at least one laser formed exit orifice in the outer wall; and

(d) a barrier layer disposed between the outer wall and the interior compartment in at least a region corresponding to the at least one exit orifice, wherein the barrier layer comprises a material that allows the barrier layer to remain intact during formation of the at least one laser formed exit orifice.

8. The dosage form of claim 7 , wherein the barrier layer is disposed between the water-soluble capsule and the outer wall.

9. The dosage form of claim 7 , wherein the barrier layer is coextensive with the water-soluble capsule.

10. The dosage form of claim 1 , wherein the material is capable of reflecting laser energy from the selected laser type under the selected laser operating conditions used to form the at least one laser formed exit orifice.

11. A dosage form comprising:

(a) an outer wall defining an interior compartment;

(b) a therapeutic agent within the interior compartment;

(c) at least one laser formed exit orifice in the outer wall; and

(d) a barrier layer disposed between the outer wall and the interior compartment in at least a region corresponding to the at least one exit orifice, wherein the barrier layer comprises a material that allows the barrier layer to remain intact during formation of the at least one laser formed exit orifice;

wherein the material is capable of reflecting laser energy from a selected laser type and under selected laser operating conditions used to form the at least one laser formed exit orifice, wherein the selected laser is a carbon dioxide laser and the material is selected from the group consisting of carbon black, powdered stainless steel, powdered nickel, powdered iron, hydrous magnesium silicate (talc), powdered glass, titanium dioxide, magnesium aluminum silicate, aluminum silicate, aluminum oxide and metallic chips or flakes.

12. The dosage form of claim 1 , wherein the material included in the barrier layer is a material capable of transmitting laser energy from a selected laser type and selected laser operating conditions used to form the at least one laser formed exit orifice.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2000
From: GEERKE, JOHAN H.
To: ALZA CORPORATION
Reel/Frame 011396/0728 →
Continuity (2)
Provisional Application 6017237100 · Dec 16, 1999
Related Publication 20020071866A1 · Jun 13, 2002